Press Releases
Biological Safety Testing Market : New Tech Developments And Advancements

, 17 February 2017 -- Biologics or biological products are medical products derived from various natural sources such as humans, microorganisms, and/or animals.

Biologics or biological products are medical products derived from various natural sources such as humans, microorganisms, and/or animals. The biological products are either extracted from sources such as proteins, sugar, and nucleic acids of living organisms, or produced by biotechnology techniques and/or other technologies. The various biological products are used to treat diseases or to prevent or diagnose diseases. Biological products include blood and blood components, vaccines, gene therapy, allergenics, somatic cells, tissues, and recombinant therapeutic proteins. The structure of different biological products are complex and difficult to identify.

For Any Queries Get Solutions With A PDF Sample :

Biologics produced through biotechnology methods are heat liable and more susceptible to microorganism contamination. Therefore, it is essential to use aseptic methods from primary manufacturing stage, in contrast to most conventional drugs. Biological products offer most effective treatment options for various medical conditions that currently have no other treatment availability. Biological safety testing is a process or method to check or ensure non-contamination of vaccines and other biological products. Biological testing is a major step in drug development to ensure quality, sterility, purity, stability, and safety of products to produce non-contaminated products. Detection, authentication, and characterization are the major steps of biological safety testing to check the biological products are whether free from bacteria, fungi, yeasts, mycoplasma, viruses, and other potential contaminants or not.

The biological safety testing market can be segmented based on product type, application, test type, end-user, and region. In terms of product type, the market can be segmented into instruments, kits & reagents, and services. Rising advancement and availability of various kits and reagents for testing are likely to drive the biological safety testing market. Based on test type, the biological safety testing market can be segmented into sterility tests, endotoxin tests, cell line authentication and characterization tests, residual host contaminant detection tests, adventitious agent detection tests, bioburden tests, and other tests such as toxicity tests, stability tests, etc.

In terms of application, the biological safety testing market can be segmented into vaccines and therapeutics, blood and blood products, tissue and tissue products, cellular and gene therapy products, and stem cell products. Vaccines is expected to be the fastest growing segment of the biological safety testing market, as these are used to prevent diseases. Increasing prevalence of chronic diseases is expected to drive the biological safety testing market during the forecast period.

Based on end-user, the biological safety testing market can be segmented into pharmaceutical companies, biotechnology companies, and contract research organizations. Pharmaceutical and biotechnology companies are expected to be the fastest growing segments of the market due to increasing R&D spending in pharmaceutical and biotechnology sectors globally. Other factors such as rapid growth in the pharmaceutical and biotechnology industries, new product launches in the biologics category, and rising government support for the development to new drugs are anticipated to fuel the market during the forecast period.

View exclusive Global strategic Business report :

In terms of region, the biological safety testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to account for the largest share of the market owing to presence of key players in these regions. Moreover, rising research and development investment by market players for development of new biological products will drive the biological safety testing market during the forecast period. Asia Pacific is the fastest growing market for biological safety testing. Growing awareness about biological products, increasing health care spending, and rising medical tourism is likely to drive the market in Asia Pacific during the forecast period.

Key players operating in the biological safety testing market are Charles River Laboratories, International, Inc., Merck Millipore, SGS S.A., B&V Testing, Avance Biosciences, and WuXi AppTec.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

# # #

Media Contacts:
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Submitted by Sandy Researcher, Transparency Market Research on Friday, 17 February 2017 at 8:35 PM
Category: Health Care & Medical
Related News

Knee Pain Specialists In Frisco, TX
Saturday, 27 May 2017

Neuroblastoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent and Other Dev
Saturday, 27 May 2017

Myocardial Infarction Therapeutics Pipeline Analysis 2017
Saturday, 27 May 2017

Global Surgical Stapling Devices Market Trends & Industry Forecast by 2016 - 2024
Friday, 26 May 2017

Global Outlook for Combined Angiography Market By Key Trends and Analysis 2024
Friday, 26 May 2017

Related Events

European Human Genetics Conference 2017
Sunday, 28 May 2017

euroPLX 64 Vienna Pharma Partnering
Monday, 29 May 2017

Strengthening Dementia Strategy
Tuesday, 30 May 2017

Reshaping the Workplace
Tuesday, 30 May 2017

2017 Vascular Annual Meeting | Society for Vascular Surgery
Wednesday, 31 May 2017

Latest News

Hebei Meite Boxing Auto Parts Manufacture Co. Ltd Presenting Metal Stamping Manufactured Products
Monday, 29 May 2017

Skiing For the duration of Austria Travel
Monday, 29 May 2017

Top Five Reasons to Pay a visit to Czech Republic
Monday, 29 May 2017

Zhejiang Mandexi Electric Equipment Co. Ltd launches power transmission & distribution equipments
Monday, 29 May 2017

Germany - Travel Location Guide
Monday, 29 May 2017

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2017
Today is Monday, 29 May 2017

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Children’s Season at the National Museum
  • Gold Ore Crusher Structure and Performance
  • 4 Step Guide to Selecting Your Perfect Corporate Gift idea
  • European Human Genetics Conference 2017
  • euroPLX 64 Vienna Pharma Partnering

  • Latest Jobs
  • London Investment Property
  • We Are Hiring A Content Manager!